Company: PCRX
Filing Date: 2025-11-06
Form Type: 10-Q
Source: 0001628280-25-050176
Chunk: 165

Company: Pacira BioSciences, Inc.
Filing Date: 2025-11-06
Form: 10-Q
Item: Part II, Item 5
Chunk 165
---
Table of Contents

Item 5. OTHER INFORMATION

Rule 10b5-1 Trading PlansThe following table shows the “Rule 10b5-1 trading arrangements” and “non-Rule 10b5-1 trading arrangements” (as each term is defined in Item 408(a) of Regulation S-K) adopted by our directors and executive officers during the quarter ended September 30, 2025. No trading arrangements were terminated by our directors and executive officers during the quarter ended September 30, 2025. Trading ArrangementName and PositionActionDateRule10b5-1*Non-Rule10b5-1**Total Number ofShares to be SoldExpirationDateJonathan SloninChief Medical OfficerAdopt8/12/2025x10,2618/28/2026Kristen WilliamsChief Administrative Officer and SecretaryAdopt9/10/2025xTo Be Determined (1)6/5/2026 * Intended to satisfy the affirmative defense of Rule 10b5-1(c).** Not intended to satisfy the affirmative defense of Rule 10b5-1(c).(1) The aggregate number of shares to be sold pursuant to the trading arrangements listed above are dependent on, among other things, sale prices under the trading arrangements and the amount of tax withholding required upon the vesting of restricted stock units, and, therefore, is indeterminable at this time.